Ronald de Vries
Max Planck Institute for Dynamics and Self-Organization(DE)Tissue Dynamics (Israel)(IL)Max Planck Institute for Multidisciplinary Sciences
Publications by Year
Research Areas
Biosimilars and Bioanalytical Methods, Pharmacogenetics and Drug Metabolism, Schizophrenia research and treatment, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study(2014)251 cited
- → A Device for Dried Blood Microsampling in Quantitative Bioanalysis: Overcoming The Issues Associated Blood Hematocrit(2014)216 cited
- → The Effect of Hematocrit on Bioanalysis of DBS: Results from The EBF DBS-Microsampling Consortium(2013)129 cited
- → Which Human Metabolites Have We MIST? Retrospective Analysis, Practical Aspects, and Perspectives For Metabolite Identification and Quantification in Pharmaceutical Development(2009)125 cited
- → Update of The EBF Recommendation for The Use of DBS in Regulated Bioanalysis Integrating The Conclusions from The EBF DBS-Microsampling Consortium(2013)110 cited
- → Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants